Clinical Trial Update: An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

View source ↗

Summary

An observational study evaluating bevacizumab (Avastin) as first-line treatment in colorectal cancer patients with potentially resectable liver metastases; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Status: COMPLETED | Results posted: 2017-04-25